Upload
nguyenhanh
View
221
Download
2
Embed Size (px)
Citation preview
Competency Based Curriculum and Evaluation
Workshop
Objectives By the end of the workshop participants will: • Be able to describe the basics of Dalhousie’s
approach to: – Competency Based Curriculum (CBC) at the
Undergraduate and – CBC and Evaluation Program Postgraduate (Family
Medicine) level
Objectives 2 – Participants will • Have discussed with colleagues the pros and cons
of a competency based curriculum in their own environment
• Decide and outline the next steps (if any) towards developing or improving their own CBC Evaluation Program
What is a competency based curriculum and evaluation program? • In pairs discuss what your definition of a
competency based curriculum is for 5 – 10 minutes then……
• How does evaluation need to change to implement an effective competency based curriculum
Ideas CBC based on your description what the learner is going to do when they complete school Evaluation designed to assess mastery of skill competencies Approach to learning – design model for curricula that uses clearly defined competencies as a framework for agreed, safe and professional practice
Ideas • Competence should encompass knowledge skills
and attitudes to achieve safe practice • Evaluation of CBC would assess against those
agreed competencies • Approach to learning that is driven by learning
outcomes • Evaluation done on definite criteria which are linked
to learning outcomes
Definition of Competence • “the habitual and judicious use of communication,
knowledge, technical skills, clinical reasoning, emotions, values, and reflection in daily practice for the benefit of the individual and community being served.”
Competency Based Curriculum • The outcome of an educational program is
determined by the competencies achieved by the learner NOT by the amount of time the learner has spent in the program
Ten Cate, O Academic Medicine 2007
Evaluation needs to be designed to be able to determine competence
Evaluation needs to be designed to be able to determine competence
Triple C Competency Based Curriculum
Evalua&on objec&ves
• “Competence will be determined by con&nuous sampling, observa&on, and reflec&on on an individual’s performances with respect to the – Six essen&al Skill Dimensions
– Phases of the clinical encounter – Priority Topics, Core Procedures and Themes – Key Features and the Observable Behaviors…………………………
20
Evaluation …………un&l the evaluator is assured and sa&sfied that the individual is competent in all six of the skill dimensions essen&al to competence in family medicine.”
WG Cer&fica&on, Evalua&on objec&ves Part 1
What are?? The Six Essen&al Skill Dimensions©
• Selec&vity • Clinical Reasoning • Pa&ent Centred Method
• Professionalism • Communica&on
• Procedural Skills
©Copyright 2010 The College of Family Physicians of Canada (CFPC)
What are??? The phases of the clinical encounter? – History -‐ Diagnosis – Physical -‐ Procedures
– Hypotheses -‐ Inves&ga&on – Management and Treatment – Referral -‐ Follow up
What are??? Priority Topics, Core Procedures and Themes© – 99 priority topics developed by family physicians across Canada
– List of essen&al procedures – Themes: Professionalism and Pa&ent Centred Method
©Copyright 2010 The College of Family Physicians of Canada (CFPC)
What are???? Key Features and the Observable Behaviors© – Each of the 99 Priority Topics has a number of key
features associated with it (this is also the blueprint for the cer&fica&on exam)
– Observable behaviours are describe under professionalism and pa&ent centred approach
©Copyright 2010 The College of Family Physicians of Canada (CFPC)
The new approach at Dalhousie Family Medicine • Detailed list of what the learning environment is
expected to provide • Field notes for clinical encounters • Evaluation form populated by field notes
Women’s Health, Maternity Care and Newborn Care
Curriculum Family Medicine Expert
!" #$%&'%()*+*,&%*-+).*/%*0&1+''&2).-+3%&.22.)04*+0+%5&6.)&)%5+3%*05&0.&+*0%,)(0%&(''&0$%&7(*89:;<=8&).'%5&+*&.)3%)&0.&64*>0+.*&%66%>0+-%'?&(5&(&,%*%)('+50&+*&0$%&2).-+5+.*&.6&&>()%&0.&*%.*(0%5&(*3&0.&1./%*&(0&(''&50(,%5&.6&0$%+)&)%2).34>0+-%&'+-%5&
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
!"#$%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
&'((% )*+*,-%./-%0112-1%123342+50+,%./-%6*3-%47%+-8943+1%47%:4./-31%80./%:-506*;<+4+=:-506*;%
64+50.04+1%>0'-'%50*9-.-1?%532,%*921-?%*2.4=0::2+-%501-*1-1?%:-506*.04+%21-?%1460*;%0112-1?%@!AB?%
%-.6C'%
&'(D%A0*,+41-%*+5%:*+*,-%64::4+%93-*1.7--50+,%E349;-:1%>0'-'%143-%+0EE;-1?%-+,43,-:-+.?%F+4.%
-+42,/%:0;GH?%5077062;.0-1%;*.6/0+,%4+C'%%
&'(I%A-16309-%./-%+2.30.04+*;%+--51%*+5%+43:*;%,348./%E*..-3+%0+%./-%7031.%8--G1%74;;480+,%903./%743%
E3-:*.23-%*+5%72;;%.-3:%0+7*+.1'%
Manager (J'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*+*,-%./-03%.0:-%
-77-6.0L-;M%.4%*..-+5%.4%84:-+%0+%;*9423%*+5%.4%0+643E43*.-%5*0;M%E41.E*3.2:%+-4+*.*;%342+51%
((%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%5-:4+1.3*.-%2+5-31.*+50+,%
47%/41E0.*;%:*.-3+*;<+-8943+%6*3-%E;*++0+,%*+5%E4;06M=:*G0+,'%
Communicator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(D'%A-L-;4E%3*EE43.?%.321.%*+5%-./06*;%./-3*E-2.06%3-;*.04+1/0E1%80./%E*.0-+.1%*+5%7*:0;0-1!(D'(%@6623*.-;M%-;060.%*+5%1M+./-10O-%0+743:*.04+!734:?%*+5%E-31E-6.0L-1%47?%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1!(D'D%@6623*.-;M%64+L-M%+--5-5%0+743:*.04+%*+5%-PE;*+*.04+1%.4%E*.0-+.1%*+5%7*:0;0-1?%64;;-*,2-1%
*+5%4./-3%E347-1104+*;1!(D'I%A-L-;4E%*%64::4+%2+5-31.*+50+,%4+%0112-1?%E349;-:1%*+5%E;*+1%80./%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1%.4%5-L-;4E?%E34L05-%*+5%74;;48=2E%4+%*%1/*3-5%E;*+%47%6*3-!(D'Q%R4+L-M%-77-6.0L-%43*;%*+5%830..-+%0+743:*.04+!
Collaborator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(I'%S43G%64;;*943*.0L-;M%0+%5077-3-+.%:45-;1%47%:*.-3+0.M%6*3-%0+6;250+,%.-*:%9*1-5%*EE34*6/-1N%
(I'(%T+,*,-%E*.0-+.1%*+5%7*:0;0-1%*1%*6.0L-%E*3.060E*+.1%0+%./-03%6*3-'%
(I'D%R4+12;.%*EE34E30*.-;M%80./%4./-3%:-:9-31%47%./-%:*.-3+0.M%6*3-%.-*:%
(I'I%A-:4+1.3*.-%-77-6.0L-%.-*:%843G%-L-+%0+%/0,/%1.3-11?%23,-+.%10.2*.04+1%5230+,%;*9423%*+5%
5-;0L-3M!
Health Advocate (Q%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%3-1E4+5%.4%0+50L052*;%
E*.0-+.%/-*;./%+--51%*+5%0112-1%*1%E*3.%47%E*.0-+.%6*3-%0+6;250+,N%
(Q'(%!5-+.07M0+,%E3-+*.*;%E*.0-+.1%8/4%*3-%L2;+-3*9;-%43%:*3,0+*;0O-5%*+5%*1101.%./-:%0+%0112-1%>-','?%
4662E*.04+*;%0112-1?%1E-60*;%50-.%*EE;06*.04+%743:1?%-.6'C%./*.%E34:4.-%./-03%/-*;./'%
(Q'D%!5-+.07M0+,%+-8943+1%*.%301G%9-6*21-%47%1460*;?%7*:0;M%43%4./-3%/-*;./%10.2*.04+1U%843G%
*EE34E30*.-;M%80./%6/0;53-+V1%E34.-6.0L-%1-3L06-1'!
Scholar (W'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*0+.*0+%*+5%-+/*+6-%
E347-1104+*;%*6.0L0.0-1%./342,/%4+,40+,%1-;7=503-6.-5%;-*3+0+,%9*1-5%4+%3-7;-6.0L-%E3*6.06-%0+%
:*.-3+0.M%*+5%+-8943+%6*3-%
(X'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%-L*;2*.-%:-506*;%
0+743:*.04+?%0.1%14236-1?%*+5%0.1%3-;-L*+6-%.4%:*.-3+0.M%*+5%+-8943+%6*3-?%*+5%*EE;M%./01%
0+743:*.04+%.4%E3*6.06-%5-60104+1%
(Y'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%7*60;0.*.-%./-%-526*.04+%47%
E*.0-+.1?%7*:0;0-1?%.3*0+--1?%4./-3%/-*;./%E347-1104+*;%64;;-*,2-1?%*+5%./-%E29;06?%*1%*EE34E30*.-%0+%
0112-1%47%:*.-3+0.M%6*3-%
!"#$%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
&'((% )*+*,-%./-%0112-1%123342+50+,%./-%6*3-%47%+-8943+1%47%:4./-31%80./%:-506*;<+4+=:-506*;%
64+50.04+1%>0'-'%50*9-.-1?%532,%*921-?%*2.4=0::2+-%501-*1-1?%:-506*.04+%21-?%1460*;%0112-1?%@!AB?%
%-.6C'%
&'(D%A0*,+41-%*+5%:*+*,-%64::4+%93-*1.7--50+,%E349;-:1%>0'-'%143-%+0EE;-1?%-+,43,-:-+.?%F+4.%
-+42,/%:0;GH?%5077062;.0-1%;*.6/0+,%4+C'%%
&'(I%A-16309-%./-%+2.30.04+*;%+--51%*+5%+43:*;%,348./%E*..-3+%0+%./-%7031.%8--G1%74;;480+,%903./%743%
E3-:*.23-%*+5%72;;%.-3:%0+7*+.1'%
Manager (J'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*+*,-%./-03%.0:-%
-77-6.0L-;M%.4%*..-+5%.4%84:-+%0+%;*9423%*+5%.4%0+643E43*.-%5*0;M%E41.E*3.2:%+-4+*.*;%342+51%
((%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%5-:4+1.3*.-%2+5-31.*+50+,%
47%/41E0.*;%:*.-3+*;<+-8943+%6*3-%E;*++0+,%*+5%E4;06M=:*G0+,'%
Communicator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(D'%A-L-;4E%3*EE43.?%.321.%*+5%-./06*;%./-3*E-2.06%3-;*.04+1/0E1%80./%E*.0-+.1%*+5%7*:0;0-1!(D'(%@6623*.-;M%-;060.%*+5%1M+./-10O-%0+743:*.04+!734:?%*+5%E-31E-6.0L-1%47?%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1!(D'D%@6623*.-;M%64+L-M%+--5-5%0+743:*.04+%*+5%-PE;*+*.04+1%.4%E*.0-+.1%*+5%7*:0;0-1?%64;;-*,2-1%
*+5%4./-3%E347-1104+*;1!(D'I%A-L-;4E%*%64::4+%2+5-31.*+50+,%4+%0112-1?%E349;-:1%*+5%E;*+1%80./%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1%.4%5-L-;4E?%E34L05-%*+5%74;;48=2E%4+%*%1/*3-5%E;*+%47%6*3-!(D'Q%R4+L-M%-77-6.0L-%43*;%*+5%830..-+%0+743:*.04+!
Collaborator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(I'%S43G%64;;*943*.0L-;M%0+%5077-3-+.%:45-;1%47%:*.-3+0.M%6*3-%0+6;250+,%.-*:%9*1-5%*EE34*6/-1N%
(I'(%T+,*,-%E*.0-+.1%*+5%7*:0;0-1%*1%*6.0L-%E*3.060E*+.1%0+%./-03%6*3-'%
(I'D%R4+12;.%*EE34E30*.-;M%80./%4./-3%:-:9-31%47%./-%:*.-3+0.M%6*3-%.-*:%
(I'I%A-:4+1.3*.-%-77-6.0L-%.-*:%843G%-L-+%0+%/0,/%1.3-11?%23,-+.%10.2*.04+1%5230+,%;*9423%*+5%
5-;0L-3M!
Health Advocate (Q%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%3-1E4+5%.4%0+50L052*;%
E*.0-+.%/-*;./%+--51%*+5%0112-1%*1%E*3.%47%E*.0-+.%6*3-%0+6;250+,N%
(Q'(%!5-+.07M0+,%E3-+*.*;%E*.0-+.1%8/4%*3-%L2;+-3*9;-%43%:*3,0+*;0O-5%*+5%*1101.%./-:%0+%0112-1%>-','?%
4662E*.04+*;%0112-1?%1E-60*;%50-.%*EE;06*.04+%743:1?%-.6'C%./*.%E34:4.-%./-03%/-*;./'%
(Q'D%!5-+.07M0+,%+-8943+1%*.%301G%9-6*21-%47%1460*;?%7*:0;M%43%4./-3%/-*;./%10.2*.04+1U%843G%
*EE34E30*.-;M%80./%6/0;53-+V1%E34.-6.0L-%1-3L06-1'!
Scholar (W'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*0+.*0+%*+5%-+/*+6-%
E347-1104+*;%*6.0L0.0-1%./342,/%4+,40+,%1-;7=503-6.-5%;-*3+0+,%9*1-5%4+%3-7;-6.0L-%E3*6.06-%0+%
:*.-3+0.M%*+5%+-8943+%6*3-%
(X'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%-L*;2*.-%:-506*;%
0+743:*.04+?%0.1%14236-1?%*+5%0.1%3-;-L*+6-%.4%:*.-3+0.M%*+5%+-8943+%6*3-?%*+5%*EE;M%./01%
0+743:*.04+%.4%E3*6.06-%5-60104+1%
(Y'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%7*60;0.*.-%./-%-526*.04+%47%
E*.0-+.1?%7*:0;0-1?%.3*0+--1?%4./-3%/-*;./%E347-1104+*;%64;;-*,2-1?%*+5%./-%E29;06?%*1%*EE34E30*.-%0+%
0112-1%47%:*.-3+0.M%6*3-%
!"#$%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
&'((% )*+*,-%./-%0112-1%123342+50+,%./-%6*3-%47%+-8943+1%47%:4./-31%80./%:-506*;<+4+=:-506*;%
64+50.04+1%>0'-'%50*9-.-1?%532,%*921-?%*2.4=0::2+-%501-*1-1?%:-506*.04+%21-?%1460*;%0112-1?%@!AB?%
%-.6C'%
&'(D%A0*,+41-%*+5%:*+*,-%64::4+%93-*1.7--50+,%E349;-:1%>0'-'%143-%+0EE;-1?%-+,43,-:-+.?%F+4.%
-+42,/%:0;GH?%5077062;.0-1%;*.6/0+,%4+C'%%
&'(I%A-16309-%./-%+2.30.04+*;%+--51%*+5%+43:*;%,348./%E*..-3+%0+%./-%7031.%8--G1%74;;480+,%903./%743%
E3-:*.23-%*+5%72;;%.-3:%0+7*+.1'%
Manager (J'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*+*,-%./-03%.0:-%
-77-6.0L-;M%.4%*..-+5%.4%84:-+%0+%;*9423%*+5%.4%0+643E43*.-%5*0;M%E41.E*3.2:%+-4+*.*;%342+51%
((%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%5-:4+1.3*.-%2+5-31.*+50+,%
47%/41E0.*;%:*.-3+*;<+-8943+%6*3-%E;*++0+,%*+5%E4;06M=:*G0+,'%
Communicator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(D'%A-L-;4E%3*EE43.?%.321.%*+5%-./06*;%./-3*E-2.06%3-;*.04+1/0E1%80./%E*.0-+.1%*+5%7*:0;0-1!(D'(%@6623*.-;M%-;060.%*+5%1M+./-10O-%0+743:*.04+!734:?%*+5%E-31E-6.0L-1%47?%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1!(D'D%@6623*.-;M%64+L-M%+--5-5%0+743:*.04+%*+5%-PE;*+*.04+1%.4%E*.0-+.1%*+5%7*:0;0-1?%64;;-*,2-1%
*+5%4./-3%E347-1104+*;1!(D'I%A-L-;4E%*%64::4+%2+5-31.*+50+,%4+%0112-1?%E349;-:1%*+5%E;*+1%80./%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1%.4%5-L-;4E?%E34L05-%*+5%74;;48=2E%4+%*%1/*3-5%E;*+%47%6*3-!(D'Q%R4+L-M%-77-6.0L-%43*;%*+5%830..-+%0+743:*.04+!
Collaborator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(I'%S43G%64;;*943*.0L-;M%0+%5077-3-+.%:45-;1%47%:*.-3+0.M%6*3-%0+6;250+,%.-*:%9*1-5%*EE34*6/-1N%
(I'(%T+,*,-%E*.0-+.1%*+5%7*:0;0-1%*1%*6.0L-%E*3.060E*+.1%0+%./-03%6*3-'%
(I'D%R4+12;.%*EE34E30*.-;M%80./%4./-3%:-:9-31%47%./-%:*.-3+0.M%6*3-%.-*:%
(I'I%A-:4+1.3*.-%-77-6.0L-%.-*:%843G%-L-+%0+%/0,/%1.3-11?%23,-+.%10.2*.04+1%5230+,%;*9423%*+5%
5-;0L-3M!
Health Advocate (Q%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%3-1E4+5%.4%0+50L052*;%
E*.0-+.%/-*;./%+--51%*+5%0112-1%*1%E*3.%47%E*.0-+.%6*3-%0+6;250+,N%
(Q'(%!5-+.07M0+,%E3-+*.*;%E*.0-+.1%8/4%*3-%L2;+-3*9;-%43%:*3,0+*;0O-5%*+5%*1101.%./-:%0+%0112-1%>-','?%
4662E*.04+*;%0112-1?%1E-60*;%50-.%*EE;06*.04+%743:1?%-.6'C%./*.%E34:4.-%./-03%/-*;./'%
(Q'D%!5-+.07M0+,%+-8943+1%*.%301G%9-6*21-%47%1460*;?%7*:0;M%43%4./-3%/-*;./%10.2*.04+1U%843G%
*EE34E30*.-;M%80./%6/0;53-+V1%E34.-6.0L-%1-3L06-1'!
Scholar (W'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*0+.*0+%*+5%-+/*+6-%
E347-1104+*;%*6.0L0.0-1%./342,/%4+,40+,%1-;7=503-6.-5%;-*3+0+,%9*1-5%4+%3-7;-6.0L-%E3*6.06-%0+%
:*.-3+0.M%*+5%+-8943+%6*3-%
(X'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%-L*;2*.-%:-506*;%
0+743:*.04+?%0.1%14236-1?%*+5%0.1%3-;-L*+6-%.4%:*.-3+0.M%*+5%+-8943+%6*3-?%*+5%*EE;M%./01%
0+743:*.04+%.4%E3*6.06-%5-60104+1%
(Y'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%7*60;0.*.-%./-%-526*.04+%47%
E*.0-+.1?%7*:0;0-1?%.3*0+--1?%4./-3%/-*;./%E347-1104+*;%64;;-*,2-1?%*+5%./-%E29;06?%*1%*EE34E30*.-%0+%
0112-1%47%:*.-3+0.M%6*3-%
!"#$%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
&'((% )*+*,-%./-%0112-1%123342+50+,%./-%6*3-%47%+-8943+1%47%:4./-31%80./%:-506*;<+4+=:-506*;%
64+50.04+1%>0'-'%50*9-.-1?%532,%*921-?%*2.4=0::2+-%501-*1-1?%:-506*.04+%21-?%1460*;%0112-1?%@!AB?%
%-.6C'%
&'(D%A0*,+41-%*+5%:*+*,-%64::4+%93-*1.7--50+,%E349;-:1%>0'-'%143-%+0EE;-1?%-+,43,-:-+.?%F+4.%
-+42,/%:0;GH?%5077062;.0-1%;*.6/0+,%4+C'%%
&'(I%A-16309-%./-%+2.30.04+*;%+--51%*+5%+43:*;%,348./%E*..-3+%0+%./-%7031.%8--G1%74;;480+,%903./%743%
E3-:*.23-%*+5%72;;%.-3:%0+7*+.1'%
Manager (J'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*+*,-%./-03%.0:-%
-77-6.0L-;M%.4%*..-+5%.4%84:-+%0+%;*9423%*+5%.4%0+643E43*.-%5*0;M%E41.E*3.2:%+-4+*.*;%342+51%
((%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%5-:4+1.3*.-%2+5-31.*+50+,%
47%/41E0.*;%:*.-3+*;<+-8943+%6*3-%E;*++0+,%*+5%E4;06M=:*G0+,'%
Communicator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(D'%A-L-;4E%3*EE43.?%.321.%*+5%-./06*;%./-3*E-2.06%3-;*.04+1/0E1%80./%E*.0-+.1%*+5%7*:0;0-1!(D'(%@6623*.-;M%-;060.%*+5%1M+./-10O-%0+743:*.04+!734:?%*+5%E-31E-6.0L-1%47?%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1!(D'D%@6623*.-;M%64+L-M%+--5-5%0+743:*.04+%*+5%-PE;*+*.04+1%.4%E*.0-+.1%*+5%7*:0;0-1?%64;;-*,2-1%
*+5%4./-3%E347-1104+*;1!(D'I%A-L-;4E%*%64::4+%2+5-31.*+50+,%4+%0112-1?%E349;-:1%*+5%E;*+1%80./%E*.0-+.1%*+5%7*:0;0-1?%
64;;-*,2-1%*+5%4./-3%E347-1104+*;1%.4%5-L-;4E?%E34L05-%*+5%74;;48=2E%4+%*%1/*3-5%E;*+%47%6*3-!(D'Q%R4+L-M%-77-6.0L-%43*;%*+5%830..-+%0+743:*.04+!
Collaborator K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4N%
(I'%S43G%64;;*943*.0L-;M%0+%5077-3-+.%:45-;1%47%:*.-3+0.M%6*3-%0+6;250+,%.-*:%9*1-5%*EE34*6/-1N%
(I'(%T+,*,-%E*.0-+.1%*+5%7*:0;0-1%*1%*6.0L-%E*3.060E*+.1%0+%./-03%6*3-'%
(I'D%R4+12;.%*EE34E30*.-;M%80./%4./-3%:-:9-31%47%./-%:*.-3+0.M%6*3-%.-*:%
(I'I%A-:4+1.3*.-%-77-6.0L-%.-*:%843G%-L-+%0+%/0,/%1.3-11?%23,-+.%10.2*.04+1%5230+,%;*9423%*+5%
5-;0L-3M!
Health Advocate (Q%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%3-1E4+5%.4%0+50L052*;%
E*.0-+.%/-*;./%+--51%*+5%0112-1%*1%E*3.%47%E*.0-+.%6*3-%0+6;250+,N%
(Q'(%!5-+.07M0+,%E3-+*.*;%E*.0-+.1%8/4%*3-%L2;+-3*9;-%43%:*3,0+*;0O-5%*+5%*1101.%./-:%0+%0112-1%>-','?%
4662E*.04+*;%0112-1?%1E-60*;%50-.%*EE;06*.04+%743:1?%-.6'C%./*.%E34:4.-%./-03%/-*;./'%
(Q'D%!5-+.07M0+,%+-8943+1%*.%301G%9-6*21-%47%1460*;?%7*:0;M%43%4./-3%/-*;./%10.2*.04+1U%843G%
*EE34E30*.-;M%80./%6/0;53-+V1%E34.-6.0L-%1-3L06-1'!
Scholar (W'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%:*0+.*0+%*+5%-+/*+6-%
E347-1104+*;%*6.0L0.0-1%./342,/%4+,40+,%1-;7=503-6.-5%;-*3+0+,%9*1-5%4+%3-7;-6.0L-%E3*6.06-%0+%
:*.-3+0.M%*+5%+-8943+%6*3-%
(X'%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%-L*;2*.-%:-506*;%
0+743:*.04+?%0.1%14236-1?%*+5%0.1%3-;-L*+6-%.4%:*.-3+0.M%*+5%+-8943+%6*3-?%*+5%*EE;M%./01%
0+743:*.04+%.4%E3*6.06-%5-60104+1%
(Y'%%%K/-%;-*3+0+,%-+L034+:-+.%80;;%E34L05-%4EE43.2+0.0-1%743%3-105-+.1%.4%7*60;0.*.-%./-%-526*.04+%47%
E*.0-+.1?%7*:0;0-1?%.3*0+--1?%4./-3%/-*;./%E347-1104+*;%64;;-*,2-1?%*+5%./-%E29;06?%*1%*EE34E30*.-%0+%
0112-1%47%:*.-3+0.M%6*3-%
!"#$%&'#()*+,(-'%$*&,'.&(+)(/$,012(3'#040.'(5.06'*70&2(+)("18'*&$($.#(-'%$*&,'.&(+)(/$,012(3'#040.'(9:''.;7(4+,%'&'.42(#+4:,'.&7(
Professional !"##$%&#'&()*+*,#&*-+).*/&*0#1+''#2).-+3&#.22.)04*+0+&5#6.)#)&5+3&*05#0.#3&/.*50)(0&##7.//+0/&*08#!"9!#$.#0%&+)#2(0+&*05:#2).6&55+.*:#(*3#5.7+&0;#0%).4,%#&0%+7('#2)(70+7&#!"9<#$.#2%;5+7+(*#%&('0%#(*3#5450(+*(=')(70+7&#!"9>#$.#)&6'&70+-)(70+7&!!?9##$%&#'&()*+*,#&*-+).*/&*0#1+''#2).-+3&#.22.)04*+0+&5#6.)#)&5+3&*05#0.#3&/.*50)(0�%&#!<#0%&/&5#.6#2).6&55+.*('+5/#1+0%#.=5&)-(='&#=&%(-+.)5#+9&99#3(;#0.#3(;#=&%(-+.)#)&(554)&5#0%(0#0%&#)&5+3&*0#+5#)&52.*5+='&:#)&'+(='&#(*3#0)4501.)0%;#!
Field Note: Examples at your tables
Draft Family Medicine ITER See list of expected learning experiences to be provided during Family Medicine core Selectivity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escribe developing competence with examples from field notes Describe areas for focus and further development with examples from field notes Clinical Reasoning B33#1'*6#%)*$'"-/%',>*&+%,&(%0)/$*1,2%#=,:*&,'*"&%$>*22$7%C,')#-$%!"#$%&'"!$&()*%+,!&*($,!$!"#$%&'"!$!&+#$,&(%&(!#%-%#!.$,(/$.0(!"#.&1#.%')#%*&3"-:,'*"&%$/$'#:,'*1,22/7%D)*&>$%,5".'%1"::"&%,&(%-#(%32,+%1"&(*'*"&$%,&(%"-+,&*E#$%')*&>*&+%'"%1":#%'"%,%-#,$"&,52#%0-"52#:%2*$'%9*')%,%$)"-'%,&(%2"&+%'#-:%:,&,+#:#&'%02,&%F,>#$%,00-"0-*,'#%(#1*$*"&$%,&(%$#'$%,00-"0-*,'#%+",2$7%% Describe developing competence with examples from field notes Describe developing competence with examples from field notes
Graduates of Dalhousie Medical School are caring, resourceful physicians, able to work with patients, families, and colleagues to provide excellent care in many different contexts and in complex and uncertain situations. They are able to work as agents of creative change in healthcare institutions and communities.
Each of the 4 major roles has: • A goal statement • Entrustable professional activities (4-5) • Educational outcomes (4-7)
The entire curriculum is mapped to the educational outcomes under each role
Small Groups • Discuss the pros and cons, barriers and challenges
to competency based curriculum • Assign a reporter and we will report back in 10-15
minutes
Small groups A. Discuss the next steps that you could take at your
institution to move towards, or improve your competency based curriculum.
B. Discuss how you could change your evaluation system to support a competency based curriculum
Pot-Pourri • Questions of any kind….. • Principles of feed back…..
• Principles of Evaluation……
Evaluation • What problems might you encounter in evaluating
students? • What do you need to know in order to carry out an
effective evaluation? • Who should do the evaluation? • How do you communicate information to the
learners? • How can you implement an effective evaluation
system
Wrap up • One thing that you learned from todays session
• Website for family medicine documents • www.cfpc.ca
Take Home • Dalhousie Family Medicine Post Grad
– Detailed description of what the learning environment is expected to provide based on the seven CANMeds FM Roles
– Narrative Intraining Evaluation system based on field notes gathered in day to day patient encounters
Take Home 2 • Dalhousie Family Medicine Undergrad
– Outcomes for the undergraduate program defined under four roles
– Goal for the under graduate curriculum – Specific Goal for each role – Educational outcomes for each goal and role – All curriculum mapped to these overarching goals
Asante Sana!